The TG2 KO mouse was highly protected against the development of fibrotic lesions in a model of CKD by Shweke et al [48], and studies in a rodent model using a pan TG inhibitor (NTU283) demonstrated levels of protection comparable to the KO model [36]. Here, TGM2 is linked to chronic kidney disease.